167 related articles for article (PubMed ID: 1608897)
1. Differences in the enhancing effects of sodium caprate on colonic and jejunal drug absorption.
Tomita M; Sawada T; Ogawa T; Ouchi H; Hayashi M; Awazu S
Pharm Res; 1992 May; 9(5):648-53. PubMed ID: 1608897
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of colonic drug absorption by the transcellular permeation route.
Tomita M; Hayashi M; Horie T; Ishizawa T; Awazu S
Pharm Res; 1988 Dec; 5(12):786-9. PubMed ID: 3247289
[TBL] [Abstract][Full Text] [Related]
3. Role of paracellular pathway in nonelectrolyte permeation across rat colon epithelium enhanced by sodium caprate and sodium caprylate.
Sawada T; Ogawa T; Tomita M; Hayashi M; Awazu S
Pharm Res; 1991 Nov; 8(11):1365-71. PubMed ID: 1798671
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of colonic drug absorption by the paracellular permeation route.
Tomita M; Shiga M; Hayashi M; Awazu S
Pharm Res; 1988 Jun; 5(6):341-6. PubMed ID: 3244645
[TBL] [Abstract][Full Text] [Related]
5. Sodium caprate enables the blood pressure-lowering effect of Ile-Pro-Pro and Leu-Lys-Pro in spontaneously hypertensive rats by indirectly overcoming PepT1 inhibition.
Gleeson JP; Frías JM; Ryan SM; Brayden DJ
Eur J Pharm Biopharm; 2018 Jul; 128():179-187. PubMed ID: 29684535
[TBL] [Abstract][Full Text] [Related]
6. Absorption-enhancing effects of sodium caprate and palmitoyl carnitine in rat and human colons.
Shimazaki T; Tomita M; Sadahiro S; Hayashi M; Awazu S
Dig Dis Sci; 1998 Mar; 43(3):641-5. PubMed ID: 9539662
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of intestinal absorption and mucosal toxicity using two promoters. II. Rat instillation and perfusion studies.
Maher S; Wang X; Bzik V; McClean S; Brayden DJ
Eur J Pharm Sci; 2009 Nov; 38(4):301-11. PubMed ID: 19664704
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of jejunal and colonic absorption of fosfomycin by promoters in the rat.
Ishizawa T; Hayashi M; Awazu S
J Pharm Pharmacol; 1987 Nov; 39(11):892-5. PubMed ID: 2892912
[TBL] [Abstract][Full Text] [Related]
9. Effect of permeability enhancers on paracellular permeability of acyclovir.
Ates M; Kaynak MS; Sahin S
J Pharm Pharmacol; 2016 Jun; 68(6):781-90. PubMed ID: 27061718
[TBL] [Abstract][Full Text] [Related]
10. Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.
Brayden DJ; Maher S; Bahar B; Walsh E
Eur J Pharm Biopharm; 2015 Aug; 94():194-206. PubMed ID: 26026287
[TBL] [Abstract][Full Text] [Related]
11. Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate: assessment of molecular weight dependence and demonstration of transport routes.
Lindmark T; Schipper N; Lazorová L; de Boer AG; Artursson P
J Drug Target; 1998; 5(3):215-23. PubMed ID: 9606011
[TBL] [Abstract][Full Text] [Related]
12. Differences in the promotion mechanism of the colonic absorption of antipyrine, phenol red and cefmetazole.
Shiga M; Hayashi M; Horie T; Awazu S
J Pharm Pharmacol; 1987 Feb; 39(2):118-23. PubMed ID: 2881996
[TBL] [Abstract][Full Text] [Related]
13. Restoration of rat colonic epithelium after in situ intestinal instillation of the absorption promoter, sodium caprate.
Wang X; Maher S; Brayden DJ
Ther Deliv; 2010 Jul; 1(1):75-82. PubMed ID: 22816121
[TBL] [Abstract][Full Text] [Related]
14. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
[TBL] [Abstract][Full Text] [Related]
15. Site-dependent effect of aprotinin, sodium caprate, Na2EDTA and sodium glycocholate on intestinal absorption of insulin.
Morishita M; Morishita I; Takayama K; Machida Y; Nagai T
Biol Pharm Bull; 1993 Jan; 16(1):68-72. PubMed ID: 7690292
[TBL] [Abstract][Full Text] [Related]
16. Excellent absorption enhancing characteristics of NO donors for improving the intestinal absorption of poorly absorbable compound compared with conventional absorption enhancers.
Fetih G; Habib F; Katsumi H; Okada N; Fujita T; Attia M; Yamamoto A
Drug Metab Pharmacokinet; 2006 Jun; 21(3):222-9. PubMed ID: 16858126
[TBL] [Abstract][Full Text] [Related]
17. Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs.
Yamamoto A; Tatsumi H; Maruyama M; Uchiyama T; Okada N; Fujita T
J Pharmacol Exp Ther; 2001 Jan; 296(1):84-90. PubMed ID: 11123366
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic analysis of the absorption enhancing action of decanoic acid and its derivatives in rats.
Takahashi K; Murakami T; Kamata A; Yumoto R; Higashi Y; Yata N
Pharm Res; 1994 Mar; 11(3):388-92. PubMed ID: 8008704
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic analysis for drug permeation through intestinal membrane.
Hayashi M; Tomita M
Drug Metab Pharmacokinet; 2007 Apr; 22(2):67-77. PubMed ID: 17495413
[TBL] [Abstract][Full Text] [Related]
20. Absorption-enhancing mechanism of sodium caprate and decanoylcarnitine in Caco-2 cells.
Tomita M; Hayashi M; Awazu S
J Pharmacol Exp Ther; 1995 Feb; 272(2):739-43. PubMed ID: 7853188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
